Chest Orthosis
Product Documents
|
 This is an article on how to diminish pain from rib fracture. Clinical research that patients whose doctors used Chrisofix chest orthosis responded with :- Quicker pain reduction (p<0.05) Accelerated recovery of respiratory functions (p<0.01) Reduced risk of pneumonia Breathable and waterproof Newest information Based on a retrospective comparison, Chrisofix Chest Orthesis has been shown to reduce the duration of hospitalisation by two to three days. |
Clinical Summary on the development of a Chest orthesis (for rib fractures.)
To diminish pain after rib fractures patient's breathing becomes superficial. The superficial breathing increase the risk of pneumonia, the most frequent late complication. By the time, patients with rib fractures are treated with analgesics and/or with a thorax belt, which reduces the pain but aggravates the breathing.
Now, the thorax orthesis covers only the fracture region and does not inhibit the breathing. On the contrary, it reduces the fracture pain, and through that improves the intensity of breathing. The improvement of respiratory functions starts with the pain reduction immediately after the application of orthesis as it has been proven clinically and spirometrically (see below).
This chest orthesis can be applicated without heating, water, or any special instrument within one minute and can be wear for more than 10 days even in shower bath.
The result of an explorative single blind study
The pain intensity was assessed in 90 patients (72 splinted and 18 control) treated for fracture of 1 to 6 ribs. A visual analogue scale method was used before, as well as 1-2, 24, 48 and 72 hours after the enrolment into the study.
Compared to the control patients, the chest support significantly (p<0.05) reduced the pain intensity assessed in rest and even more (p<0.01) at forced inspiration (e.g. cough) during the 48 hours observation period. In 41 patients, spirometry was also performed before, and 1-2, 24, 48 or 72 hours (in some cases at every time) after the application of the orthesis or a control textile piece of the same size. Depending on the extension of the fractured region two different sizes were used, i.e., 12x17 or 17x17 cm.
Compared to the admission, the forced vital capacity (FVC) became further reduced (-154 ml) during the first 2 hours and only slowly improved after 24, 48 and 72 hours (-134, -31 and +164 ml in average, respectively) in the controls. In the 29 patients treated with the Chrisofix orthesis, the FVC continuously increased during the whole observation period, i.e., in average by +161, +301, +410 and +616 ml after 1-2, 24, 48 and 72 hours, respectively. These values represent a highly significant (p<0.001) acceleration in the recovery of the FVC due to the application of the Chrisofix Chest Orthesis. Similar trend was seen also in some other spirometric parameters (FEV1, or PEF).
In the mean time, this observation has been confirmed by feedback on the first observations from different European countries like Belgium, Germany, Spain and Switzerland.
